Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX), Biogen (BIIB) and Emergent Biosolutions
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX – Research
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More
12:55pm, Friday, 01'st May 2020
Remdesivir, the investigational Gilead Sciences antiviral drug, looks more likely than ever to become the first treatment authorized by the FDA to treat
Ken Fisher's Top 5 1st-Quarter Buys
05:12pm, Wednesday, 29'th Apr 2020
Guru’s largest new position is Advanced Micro Devices Continue reading...
Aurinia Taps Cerecor's Miller to Succeed Retiring Chief Financial Officer
11:58pm, Tuesday, 28'th Apr 2020
Aurinia Pharmaceuticals (NASDAQ: ]) announced that Joe Miller would become its new chief financial officer, succeeding Dennis Bourgeault, who is retiring
Aurinia Appoints Joe Miller as Chief Financial Officer
10:06am, Monday, 27'th Apr 2020
– Dennis Bourgeault to retire after more than 20 years with the company –VICTORIA, British Columbia & ROCKVILLE, Md. — Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia…
Aurinia Appoints Joe Miller as Chief Financial Officer
10:05am, Monday, 27'th Apr 2020
Aurinia Appoints Joe Miller as Chief Financial Officer
Short Interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Declines By 6.7%
10:18am, Wednesday, 22'nd Apr 2020
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) saw a large decline in short interest in March. As of March 31st, there was short interest totalling 4,990,000 shares, a decline of 6.7% from the Ma
One Thing To Remember About The Aurinia Pharmaceuticals Inc. (TSE:AUP) Share Price
11:33am, Tuesday, 21'st Apr 2020
Anyone researching Aurinia Pharmaceuticals Inc. (TSE:AUP) might want to consider the historical volatility of the...
Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors
10:06am, Monday, 20'th Apr 2020
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multip…
Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors
10:05am, Monday, 20'th Apr 2020
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today annou
Better Buy: Amarin vs. Aurinia Pharmaceuticals
01:43pm, Sunday, 19'th Apr 2020
Could both of these volatile stocks be winners in the long run?
Assenagon Asset Management S.A. Makes New $14.49 Million Investment in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)
10:46am, Sunday, 19'th Apr 2020
Assenagon Asset Management S.A. acquired a new position in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) during the 1st quarter, according to the company in its most recent disclosure
Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI), Madrigal Pharmaceuticals (MDGL) and CareDx (CDNA)
11:22am, Wednesday, 15'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics (BTAI), Madrigal Pharmaceuticals
